Gr?thal GmbH: Aachen (ots) - The German pharmaceutical company Grunenthal
announces its worldwide exclusive rights on trimegestone for the use
in oral contraception by Aventis Pharma, SA, France, a subsidiary of
sanofi-aventis. Thereby the firm extends its ...

presseportal.de